QUADRANT HEALTH Trademark

Trademark Overview


On Thursday, December 19, 2024, a trademark application was filed for QUADRANT HEALTH with the United States Patent and Trademark Office. The USPTO has given the QUADRANT HEALTH trademark a serial number of 98912567. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, June 5, 2025. This trademark is owned by Quadrant Technologies, Inc.. The QUADRANT HEALTH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software development in the framework of software publishing
quadrant health

General Information


Serial Number98912567
Word MarkQUADRANT HEALTH
Filing DateThursday, December 19, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, June 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSoftware development in the framework of software publishing

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 19, 2024
Primary Code042
First Use Anywhere DateWednesday, September 30, 2020
First Use In Commerce DateWednesday, September 30, 2020

Trademark Owner History


Party NameQuadrant Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94114

Trademark Events


Event DateEvent Description
Thursday, December 19, 2024NEW APPLICATION ENTERED
Tuesday, May 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 5, 2025ASSIGNED TO EXAMINER
Thursday, June 5, 2025NON-FINAL ACTION E-MAILED
Thursday, June 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 5, 2025NON-FINAL ACTION WRITTEN